| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $26K | -96.3% |
| SG&A Expense | $3.8M | -60.3% |
| Operating Income | -$3.8M | +62.8% |
| Net Income | -$9.5M | +91.7% |
| EPS (Basic) | -$0.34 | +92.2% |
| EPS (Diluted) | -$0.34 | +92.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $812K | -61.5% |
| Total Assets | $902K | -83.6% |
| Current Liabilities | $33.9M | +12.9% |
| Total Liabilities | $98.5M | +2.3% |
| Stockholders' Equity | -$97.6M | -7.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.2M | +55.7% |
| Financing Cash Flow | $3.4M | -67.3% |